Recruiting PHASE4 INTERVENTIONAL 1-arm NCT06346262

Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care

Sponsor: University Hospitals Cleveland Medical Center

Conditions Epilepsy

Interventions SMART RM Valtoco Nasal Product

Updated 6 times since 2024 Last updated: Feb 5, 2026 Started: Mar 5, 2024 Primary completion: Sep 1, 2026 Completion: Sep 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06346262, this PHASE4 trial focuses on Epilepsy and remains actively recruiting participants. Sponsored by University Hospitals Cleveland Medical Center, it has been updated 6 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE4
Jan 2026 — Feb 2026 [monthly]

Recruiting PHASE4
Jan 2025 — Jan 2026 [monthly]

Recruiting PHASE4
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

May 2024 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States